Everest Medicines Limited has released a reminder dated 24 April 2026 reaffirming its shift to fully electronic dissemination of corporate communications.

The company first announced the arrangement on 6 September 2024. Under Hong Kong Stock Exchange Listing Rule 2.07A, actionable corporate communications—including annual reports, interim reports, circulars, meeting notices and proxy forms—will be distributed by email once shareholders provide a functional address. Both English and Chinese versions of every document will be posted on the company’s website (www.everestmedicines.com) and HKEx’s website (www.hkexnews.hk); printed copies will no longer be sent automatically.

Shareholders who have not yet supplied an email address are urged to: 1. Scan the personalized QR code on the enclosed reply form to register an email address; or 2. Return the signed reply form to the Hong Kong Share Registrar, Computershare Hong Kong Investor Services Limited.

If no valid email address is received, future actionable corporate communications will be mailed in hard copy until an email is registered. Shareholders may also opt to receive printed documents for one year by emailing everestmedicines.ecom@computershare.com.hk and providing name, address and the print request.

Everest Medicines underscores the importance of accurate contact information to avoid delays in receiving shareholder materials. Queries can be directed to the registrar at everestmedicines.ecom@computershare.com.hk.